Skip to main content
. 2015 Jan 31;12:7. doi: 10.1186/s12950-015-0048-5

Figure 2.

Figure 2

Analysis of inflammasome components expression after LOVA+LPS treatment (a) representative western blot : untreated condition (UNT), lovastatin (LOVA) 10μM, LPS 0.5 ng/ml, LOVA + LPS double treatment. (b) optical density calculation of MVK protein levels: n.s.: non significant differences * = p < 0.05 (c) optical density calculation of NALP3 protein levels: n.s.: non significant differences * = p < 0.05.